Health Care/Hospital
Key milestone: DHL delivers 1 billion COVID-19 vaccine doses
* 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 sinceDecember 2020 * Smooth management and execution of different supply chain set-ups * Planning essential to identify and prevent future health emergencies SINGAPORE, Sept. 16, 2021 /PRNewswire/ -- C...
2021-09-16 16:00
14877
Beyond Ventures' first investment, Prenetics, becomes first Hong Kong unicorn to go public
HONG KONG, Sept. 16, 2021 /PRNewswire/ -- Hong Kong-based venture capital firm Beyond Ventures is pleased to support today's announcement by the firm's first investee company, Prenetics, that Prenetics, a global leader in genomic and diagnostic testing is set to merge with Artisan Acquisition Cor...
2021-09-16 15:31
1881
PR Newswire's 2021 Healthcare Media Pitching Kit (APAC Edition) Reveals News and Trends Journalists Seek from Brands
HONG KONG, Sept. 16, 2021 /PRNewswire/-- COVID-19 related stories will stay dominant in healthcare media coverage and journalists are keen to report on medical innovations, scientific discoveries and technical applications, according to PR Newswire's 2021 Healthcare Media Pitching Kit (APAC Editi...
2021-09-16 10:00
3346
Allianz Partners expands its Digital Health Assistant to ten markets in Asia-Pacific
* Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals * This digital health offer is part of Allianz Partners' new Digital Access to Care Initiative BEIJING, Sept. 16, 2021 /PRNewswire/ -- Responding to a growin...
2021-09-16 09:00
2531
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
SYDNEY, Sept. 16, 2021 /PRNewswire/ -- SuperTrans Medical ("STM"), a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multi-drug resistant bacterial infections, has announced that the U.S. National Institutes of Health (NIH) will be supporting additional dev...
2021-09-16 08:45
2181
Charles Bodner Joins CSafe Global as Chief Financial Officer
CSafe Global has hired Charles Bodner as CFO following Patrick Schafer's promotion to CEO in 2020. DAYTON, Ohio, Sept. 16, 2021 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner h...
2021-09-16 06:25
2341
Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly Traded on the Nasdaq via Merger with Adrian Cheng's Artisan Acquisition Corp.
* Prenetics' mission is to disrupt and decentralise the healthcare industry with a global opportunity of overUS$1.3 trillion. * Prenetics' multi-product healthcare ecosystem strategy is driven by prevention focused genomic testing, rapid diagnostics for COVID-19 and infectious diseases, and c...
2021-09-16 06:00
6585
Onyx Acclaimed by Frost & Sullivan for Facilitating Health Data Interoperability with Its SAFHIR Platform
Onyx's SAFHIR makes data systems compliant with federal regulations and enables the future of health data sharing SANTA CLARA, Calif., Sept. 15, 2021 /PRNewswire/ -- Based on its recent analysis of the North American healthcare data interoperability market,Frost & Sullivan recognizes Onyx Health...
2021-09-15 21:00
1679
Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform
CLEVELAND and LONDON, Sept. 15, 2021 /PRNewswire/ -- Within3's hybrid engagement platform is proven to increase the volume, quality, and value of insights generated by life science innovators, their key opinion leaders, patients, and other stakeholders. That's why multidisciplinary teams in the ...
2021-09-15 20:48
2154
Top Organizations Honored with Frost & Sullivan Asia-Pacific Best Practices Awards
In celebration of the award recipients, the second edition of Frost & Sullivan's 2021 Asia-Pacific Best Practices Virtual Awards Ceremony will be broadcasted live onSeptember 22, 2021, at 6:00 p.m. (GMT +8). SINGAPORE, Sept. 15, 2021 /PRNewswire/ -- Frost & Sullivan Best Practices Awards honor 2...
2021-09-15 20:34
1903
ThinkSono DVT detection software results are published in Nature digital medicine (npj)
LONDON and POTSDAM, Germany, Sept. 15, 2021 /PRNewswire/ -- A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, pot...
2021-09-15 19:34
1973
2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19
LONDON, Sept. 15, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of the2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook. The 2021 CMR ...
2021-09-15 16:00
1389
Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus
MOSCOW, Sept. 15, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of theRepublic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campai...
2021-09-15 16:00
1465
iGene Laboratory donates 25,000 SARS-CoV-2 PCR Kits to Indonesia
SINGAPORE, Sept. 15, 2021 /PRNewswire/ -- iGene Laboratory Pte. Ltd donates 25,000 SARS-CoV-2 PCR Kits toIndonesia to assist the government of the Republic ofIndonesia in managing the COVID-19 disease outbreak. The occasion was marked with a symbolic hand-over ceremony at the Republic of Indonesi...
2021-09-15 10:22
1919
CStone received China NMPA IND approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody, marking further expansion of its Pipeline 2.0
SUZHOU, China, Sept. 15, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigational ne...
2021-09-15 08:30
2290
Humanforce Releases Solution to Help Employers Manage COVID-19 Vaccination Policies
SYDNEY, Sept. 15, 2021 /PRNewswire/ -- As increasing vaccination rates become a primary path towards reopeningAustralia, local workers are indicating a preference to work in environments where their colleagues are vaccinated. To assist businesses in managing complex workplace vaccination issues,H...
2021-09-15 07:00
1830
Point-of-Care Ultrasound World Conference - September 17-18, 2021 Hosted by the Point-of-Care Ultrasound Certification Academy
Medical professionals from around the world gather to help define point-of-care ultrasound standards ROCKVILLE, Md., Sept. 14, 2021 /PRNewswire/ -- The global point-of-care ultrasound (POCUS) community of physicians, researchers and healthcare providers, will gather virtually at the2021 POCUS Wo...
2021-09-14 21:01
1296
PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever
HONG KONG, Sept. 14, 2021 /PRNewswire/ -- Researchers at The Hong Kong Polytechnic University (PolyU) have developed a groundbreaking, imaging-guided nanoparticle photothermal treatment for osteoarthritis pain, utilising the concept of targeted cancer therapy but instead applied to the protein th...
2021-09-14 20:37
1701
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs
VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...
2021-09-14 15:00
5006
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002
SHANGHAI, Sept. 14, 2021 /PRNewswire/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-center, rand...
2021-09-14 11:43
2420
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 318 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 301 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
8601
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
7969
Where does China's production capacity come from?
2024-05-10 12:01
7807
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4977